Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...

In February, Mylan launched the first generic at a 70% discount to GSK’s brand – Wixela Inhub – which was also rejected by the FDA at the first attempt in 2017. Since the launch, Advair’s ...